AMGEN INC (AMGN) Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Amgen Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Amgen Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $45 M, a 92.5% decline year-over-year.
  • Amgen Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $582 M, a 51.3% decline year-over-year.
  • Amgen Inc annual Income Tax Expense (Benefit) for 2023 was $1.14 B, a 43.3% increase from 2022.
  • Amgen Inc annual Income Tax Expense (Benefit) for 2022 was $794 M, a 1.73% decline from 2021.
  • Amgen Inc annual Income Tax Expense (Benefit) for 2021 was $808 M, a 7.02% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $582 M $45 M -$556 M -92.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $1.14 B $85 M -$47 M -35.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $1.19 B $217 M -$32 M -12.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $1.22 B $235 M +$21 M +9.81% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $1.2 B $601 M +$402 M +202% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $794 M $132 M -$100 M -43.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $894 M $249 M -$22 M -8.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $916 M $214 M +$120 M +128% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $796 M $199 M -$12 M -5.69% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $808 M $232 M -$30 M -11.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $838 M $271 M +$86 M +46.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $752 M $94 M -$133 M -58.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $885 M $211 M +$16 M +8.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $869 M $262 M -$18 M -6.43% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $887 M $185 M -$124 M -40.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.01 B $227 M -$158 M -41% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.17 B $195 M -$127 M -39.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $1.3 B $280 M +$23 M +8.95% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $1.27 B $309 M +$74 M +31.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.2 B $385 M +$34 M +9.69% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $1.17 B $322 M +$14 M +4.55% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $1.15 B $257 M -$6.22 B -96% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $7.37 B $235 M -$125 M -34.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $7.5 B $351 M -$40 M -10.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $7.54 B $308 M -$81 M -20.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $7.62 B $6.48 B +$6.13 B +1761% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $1.49 B $360 M -$41 M -10.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $1.53 B $391 M +$57 M +17.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $1.47 B $389 M +$31 M +8.66% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $1.44 B $348 M +$235 M +208% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $1.21 B $401 M +$72 M +21.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $1.13 B $334 M -$10 M -2.91% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $1.14 B $358 M +$105 M +41.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $1.04 B $113 M +$121 M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $918 M $329 M +$236 M +254% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $682 M $344 M +$133 M +63% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $549 M $253 M +$122 M +93.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $427 M -$8 M -$1 M -14.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $428 M $93 M -$42 M -31.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $470 M $211 M +$64 M +43.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $406 M $131 M +$222 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $184 M -$7 M -$142 M -105% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $326 M $135 M -$21 M -13.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $347 M $147 M -$44 M -23% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $391 M -$91 M -$273 M -150% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $664 M $135 M +$18 M +15.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $646 M $156 M +$156 M Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $490 M $191 M +$22 M +13% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $468 M $182 M +$1 M +0.55% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $467 M $117 M +$140 M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $327 M $0 -$198 M -100% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $525 M $169 M -$93 M -35.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $618 M $181 M -$72 M -28.5% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $690 M -$23 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $198 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $262 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $253 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.